For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Arm A1 | Module A: nivolumab 3 mg/kg every 2 weeks. Cohort 1: participants with newly-diagnosed DIPG, including midline glioma with H3K27M mutation. | 18 | None | 17 | 23 | 22 | 23 | View |
| Arm B1 | Module B: nivolumab 3 mg/kg + ipilimumab 1 mg/kg every 3 weeks, for 4 doses, then nivolumab 3 mg/kg every 2 weeks thereafter. Cohort 1: participants with newly-diagnosed DIPG, including midline glioma with H3K27M mutation. | 18 | None | 16 | 22 | 21 | 22 | View |
| Arm A2 | Module A: nivolumab 3 mg/kg every 2 weeks. Cohort 2: participants with recurrent or progressive non-brainstem HGG, regardless of mutation status, including glioblastoma. | 12 | None | 13 | 16 | 15 | 16 | View |
| Arm B2 | Module B: nivolumab 3 mg/kg + ipilimumab 1 mg/kg every 3 weeks, for 4 doses, then nivolumab 3 mg/kg every 2 weeks thereafter. Cohort 2: participants with recurrent or progressive non-brainstem HGG, regardless of mutation status, including glioblastoma. | 13 | None | 12 | 15 | 14 | 15 | View |
| Arm A3 | Module A: nivolumab 3 mg/kg every 2 weeks. Cohort 3: participants with relapsed or resistant medulloblastoma. | 12 | None | 7 | 15 | 14 | 15 | View |
| Arm B3 | Module B: nivolumab 3 mg/kg + ipilimumab 1 mg/kg every 3 weeks, for 4 doses, then nivolumab 3 mg/kg every 2 weeks thereafter. Cohort 3: participants with relapsed or resistant medulloblastoma. | 11 | None | 10 | 15 | 14 | 15 | View |
| Arm A4 | Module A: nivolumab 3 mg/kg every 2 weeks. Cohort 4: participants with relapsed or resistant ependymoma. | 9 | None | 11 | 12 | 11 | 12 | View |
| Arm B4 | Module B: nivolumab 3 mg/kg + ipilimumab 1 mg/kg every 3 weeks, for 4 doses, then nivolumab 3 mg/kg every 2 weeks thereafter. Cohort 4: participants with relapsed or resistant ependymoma. | 7 | None | 6 | 10 | 10 | 10 | View |
| Arm A5 | Module A: nivolumab 3 mg/kg every 2 weeks. Cohort 5: participants with other recurrent subtypes of high-grade CNS malignancy (eg, pineoblastoma, AT/RT, germ cell tumor, and others). | 18 | None | 14 | 19 | 18 | 19 | View |
| Arm B5 | Module B: nivolumab 3 mg/kg + ipilimumab 1 mg/kg every 3 weeks, for 4 doses, then nivolumab 3 mg/kg every 2 weeks thereafter. Cohort 5: participants with other recurrent subtypes of high-grade CNS malignancy (eg, pineoblastoma, AT/RT, germ cell tumor, and others). | 15 | None | 15 | 19 | 18 | 19 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Pyrexia | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Autoimmune hepatitis | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 24.1 | View |
| Hepatitis | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 24.1 | View |
| Hepatitis acute | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 24.1 | View |
| Haemophagocytic lymphohistiocytosis | SYSTEMATIC_ASSESSMENT | Immune system disorders | 24.1 | View |
| Hypersensitivity | SYSTEMATIC_ASSESSMENT | Immune system disorders | 24.1 | View |
| Immune-mediated adverse reaction | SYSTEMATIC_ASSESSMENT | Immune system disorders | 24.1 | View |
| Anaemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 24.1 | View |
| Vision blurred | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Ascites | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Colitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Diarrhoea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Enterocolitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Gastric ulcer | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Gastritis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Immune-mediated enterocolitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Pancreatitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| General physical health deterioration | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Multisystem inflammatory syndrome in children | SYSTEMATIC_ASSESSMENT | Immune system disorders | 24.1 | View |
| Bacterial infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Coronavirus infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Device related infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Diarrhoea infectious | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Escherichia urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Gastroenteritis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Measles | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Pneumonia | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Respiratory tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Staphylococcal bacteraemia | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Staphylococcal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Tonsillitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Upper respiratory tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Vascular device infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Wound infection staphylococcal | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Brain herniation | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Facial bones fracture | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Infusion related reaction | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Lower limb fracture | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Shunt malfunction | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Wound dehiscence | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Aspartate aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Chest X-ray abnormal | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Gamma-glutamyltransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Hepatic enzyme increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hypercalcaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hypocalcaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hypokalaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hyponatraemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hypophagia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Steroid diabetes | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Mobility decreased | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Muscular weakness | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Spinal deformity | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Malignant neoplasm progression | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 24.1 | View |
| Neoplasm | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 24.1 | View |
| Neoplasm progression | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 24.1 | View |
| Schwannoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 24.1 | View |
| Tumour flare | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 24.1 | View |
| Tumour haemorrhage | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 24.1 | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Dysarthria | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Dyskinesia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Facial nerve disorder | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Haemorrhage intracranial | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Hemiparesis | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Hydrocephalus | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Intracranial pressure increased | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Lethargy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Motor dysfunction | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Myoclonus | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Nervous system disorder | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Neurological decompensation | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Paraesthesia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Partial seizures | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Peripheral motor neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Seizure | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Somnolence | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Status epilepticus | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Transient ischaemic attack | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Delirium | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 24.1 | View |
| Psychotic disorder | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 24.1 | View |
| Bladder dysfunction | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 24.1 | View |
| Urinary incontinence | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 24.1 | View |
| Aspiration | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Bronchospasm | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Dyspnoea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Hypoxia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Pneumonitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Respiratory failure | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Toxic skin eruption | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | 24.1 | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | 24.1 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Sinus bradycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 24.1 | View |
| Sinus tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 24.1 | View |
| Tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 24.1 | View |
| Eye discharge | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Eye haemorrhage | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Eye inflammation | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Eye irritation | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Eye movement disorder | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Eye pain | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Eye swelling | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Eyelid function disorder | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Eyelid oedema | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Eyelid ptosis | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Lacrimation increased | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Mydriasis | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Ocular hyperaemia | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Photophobia | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Pupillary reflex impaired | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Vision blurred | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Device related thrombosis | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Facial pain | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Gait disturbance | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Blood chloride decreased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Blood creatine increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Blood creatinine decreased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Blood creatinine increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Ataxia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Balance disorder | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Lethargy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Meningism | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Motor dysfunction | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Muscle spasticity | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Anaemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 24.1 | View |
| Coagulopathy | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 24.1 | View |
| Leukopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 24.1 | View |
| Lymphadenopathy | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 24.1 | View |
| Lymphopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 24.1 | View |
| Neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 24.1 | View |
| Pancytopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 24.1 | View |
| Thrombocytopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 24.1 | View |
| Von Willebrand's disease | SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | 24.1 | View |
| Deafness | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | 24.1 | View |
| Ear pain | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | 24.1 | View |
| Ear pruritus | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | 24.1 | View |
| Middle ear effusion | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | 24.1 | View |
| Motion sickness | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | 24.1 | View |
| Tinnitus | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | 24.1 | View |
| Tympanic membrane perforation | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | 24.1 | View |
| Vertigo | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | 24.1 | View |
| Cushingoid | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 24.1 | View |
| Diabetes insipidus | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 24.1 | View |
| Hyperthyroidism | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 24.1 | View |
| Hypothyroidism | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 24.1 | View |
| Blepharospasm | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Blindness | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Conjunctival hyperaemia | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Corneal epithelium defect | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Diplopia | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Dry eye | SYSTEMATIC_ASSESSMENT | Eye disorders | 24.1 | View |
| Abdominal distension | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Abdominal pain upper | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Anal erythema | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Anal fissure | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Anal haemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Anal incontinence | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Chronic gastritis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Colitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Diarrhoea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Dry mouth | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Duodenal ulcer | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Duodenitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Dyspepsia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Dysphagia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Flatulence | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Gastric ulcer | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Gastritis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Gastrooesophageal reflux disease | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Immune-mediated enterocolitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Lip swelling | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Loose tooth | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Mouth ulceration | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Oral dysaesthesia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Paraesthesia oral | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Periodontal disease | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Post-tussive vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Proctalgia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Salivary hypersecretion | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Stomatitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Tongue oedema | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Toothache | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 24.1 | View |
| Application site pruritus | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Asthenia | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Chills | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| General physical health deterioration | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Generalised oedema | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Hypothermia | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Influenza like illness | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Mucosal inflammation | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Non-cardiac chest pain | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Oedema peripheral | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Pain | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Pyrexia | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Sensation of foreign body | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Xerosis | SYSTEMATIC_ASSESSMENT | General disorders | 24.1 | View |
| Hepatitis acute | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 24.1 | View |
| Hyperbilirubinaemia | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 24.1 | View |
| Drug hypersensitivity | SYSTEMATIC_ASSESSMENT | Immune system disorders | 24.1 | View |
| Hypersensitivity | SYSTEMATIC_ASSESSMENT | Immune system disorders | 24.1 | View |
| Infusion related hypersensitivity reaction | SYSTEMATIC_ASSESSMENT | Immune system disorders | 24.1 | View |
| Seasonal allergy | SYSTEMATIC_ASSESSMENT | Immune system disorders | 24.1 | View |
| Bronchitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Catheter site infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Clostridium difficile infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Ear infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Enterobiasis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Eye infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Febrile infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Fungal skin infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Gastroenteritis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Gastroenteritis Escherichia coli | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Herpes zoster | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Infection parasitic | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Influenza | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Lip infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Localised infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Nasopharyngitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Oral candidiasis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Oral herpes | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Otitis externa | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Otitis media | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Paronychia | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Pneumococcal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Pneumonia | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Postoperative wound infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Respiratory syncytial virus infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Respiratory tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Respiratory tract infection viral | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Rhinitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Sinusitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Sinusitis bacterial | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Tooth abscess | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Upper respiratory tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 24.1 | View |
| Arthropod bite | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Contusion | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Facial bones fracture | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Fall | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Fracture | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Head injury | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Infusion related reaction | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Mouth injury | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Procedural pain | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Shunt malfunction | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Skin abrasion | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Stoma site discharge | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Tongue injury | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Vascular access complication | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Vascular access site discharge | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Vascular access site pain | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Vascular access site rash | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Wound | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 24.1 | View |
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Amylase increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Anion gap increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Aspartate aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Blood alkaline phosphatase increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Blood bicarbonate increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Blood lactate dehydrogenase decreased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Blood lactate dehydrogenase increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Blood magnesium decreased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Blood sodium increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Blood thyroid stimulating hormone increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Blood urea increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Blood uric acid increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Gamma-glutamyltransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Haematocrit decreased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Haemoglobin decreased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Intestinal transit time increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Lipase increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Liver function test increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Lymphocyte count decreased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Mean cell volume decreased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Mean cell volume increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Neutrophil count decreased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Neutrophil count increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Platelet count decreased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Red blood cell count decreased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Red blood cell count increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Skin turgor decreased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Thyroxine free decreased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Thyroxine free increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Transaminases increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Tri-iodothyronine free increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Weight decreased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Weight increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| White blood cell count decreased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| White blood cell count increased | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| White blood cells urine positive | SYSTEMATIC_ASSESSMENT | Investigations | 24.1 | View |
| Acidosis | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Decreased appetite | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Fluid retention | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hyperammonaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hypercalcaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hyperglycaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hyperkalaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hypernatraemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hypertriglyceridaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hyperuricaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hypoalbuminaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hypocalcaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hypochloraemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hypoglycaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hypokalaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hypomagnesaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hyponatraemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Hypophosphataemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Polydipsia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 24.1 | View |
| Arthralgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Arthritis | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Back pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Dactylitis | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Mastication disorder | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Muscle spasms | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Muscular weakness | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Musculoskeletal chest pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Musculoskeletal stiffness | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Myalgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Neck pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Osteopenia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Pain in extremity | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Spinal pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Torticollis | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Trismus | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 24.1 | View |
| Malignant neoplasm progression | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 24.1 | View |
| Melanocytic naevus | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 24.1 | View |
| Myelodysplastic syndrome | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 24.1 | View |
| Allodynia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Altered state of consciousness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Amnesia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Aphasia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Areflexia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Consciousness fluctuating | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Depressed level of consciousness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Diplegia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Disturbance in attention | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Dysarthria | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Epilepsy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Facial nerve disorder | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Facial paralysis | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Facial paresis | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Haemorrhage intracranial | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Hemianopia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Hemiparesis | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Hydrocephalus | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Hypersomnia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Hypoaesthesia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| IIIrd nerve disorder | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Intracranial pressure increased | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Nervous system disorder | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Neuralgia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Neuropathy peripheral | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Neurotoxicity | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Nystagmus | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Paraesthesia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Paraparesis | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Paresis | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Partial seizures | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Presyncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Seizure | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Somnolence | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Speech disorder | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Syncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Taste disorder | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Tremor | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Trigeminal nerve disorder | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| VIth nerve disorder | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 24.1 | View |
| Anxiety | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 24.1 | View |
| Behaviour disorder | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 24.1 | View |
| Confusional state | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 24.1 | View |
| Depression | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 24.1 | View |
| Dysphemia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 24.1 | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 24.1 | View |
| Irritability | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 24.1 | View |
| Mood swings | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 24.1 | View |
| Phonophobia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 24.1 | View |
| Restlessness | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 24.1 | View |
| Sleep disorder | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 24.1 | View |
| Suicidal ideation | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 24.1 | View |
| Dysuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 24.1 | View |
| Haematuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 24.1 | View |
| Micturition urgency | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 24.1 | View |
| Neurogenic bladder | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 24.1 | View |
| Nocturia | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 24.1 | View |
| Oliguria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 24.1 | View |
| Urinary hesitation | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 24.1 | View |
| Urinary incontinence | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 24.1 | View |
| Urinary retention | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 24.1 | View |
| Testicular pain | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | 24.1 | View |
| Vaginal haemorrhage | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | 24.1 | View |
| Bronchospasm | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Dysphonia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Dyspnoea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Epistaxis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Hypoxia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Increased upper airway secretion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Nasal congestion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Nasal dryness | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Oropharyngeal pain | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Productive cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Rhinorrhoea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Sleep apnoea syndrome | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Sneezing | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Tachypnoea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Wheezing | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 24.1 | View |
| Acne | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Alopecia | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Angioedema | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Blister | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Circumoral oedema | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Decubitus ulcer | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Dermatitis allergic | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Dermatitis diaper | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Dry skin | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Eczema | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Erythema | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Keratosis pilaris | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Onychomadesis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Palmar-plantar erythrodysaesthesia syndrome | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Petechiae | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Pruritus | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Rash erythematous | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Rash macular | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Rash maculo-papular | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Rash papular | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Rash pruritic | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Skin disorder | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Skin exfoliation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Skin hypopigmentation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Skin irritation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Skin lesion | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Urticaria | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Urticaria papular | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Xeroderma | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 24.1 | View |
| Bloody discharge | SYSTEMATIC_ASSESSMENT | Vascular disorders | 24.1 | View |
| Deep vein thrombosis | SYSTEMATIC_ASSESSMENT | Vascular disorders | 24.1 | View |
| Embolism | SYSTEMATIC_ASSESSMENT | Vascular disorders | 24.1 | View |
| Extremity necrosis | SYSTEMATIC_ASSESSMENT | Vascular disorders | 24.1 | View |
| Flushing | SYSTEMATIC_ASSESSMENT | Vascular disorders | 24.1 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | 24.1 | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | 24.1 | View |